Related references
Note: Only part of the references are listed.Cytokines and Insulin Resistance after Zoledronic Acid-Induced Acute Phase Response
Georgia Kassi et al.
IMMUNOLOGICAL INVESTIGATIONS (2014)
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug
Robin J. Young et al.
FUTURE ONCOLOGY (2013)
Zoledronic Acid Inhibits Human Osteoblast Activities
Fernanda G. Basso et al.
GERONTOLOGY (2013)
Zoledronic Acid Acutely Increases Sclerostin Serum Levels in Women With Postmenopausal Osteoporosis
Antonino Catalano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data
Peter Svenssen Munksgaard et al.
GYNECOLOGIC ONCOLOGY (2011)
Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene
Sojung Lee et al.
IMMUNOLOGY (2011)
Bisphosphonates Induce Autophagy by Depleting Geranylgeranyl Diphosphate
Brian M. Wasko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Zoledronic Acid Induces Autophagic Cell Death in Human Prostate Cancer Cells
Ji-Fan Lin et al.
JOURNAL OF UROLOGY (2011)
Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines
Bulent Karabulut et al.
MOLECULAR BIOLOGY REPORTS (2011)
Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis
Keiichiro Kimachi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Zoledronic acid: an unending tale for an antiresorptive agent
Michele Caraglia et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation
Andreas Guenther et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Bone Metastasis in Cervical Cancer Patients Over a 10-Year Period
Duangmani Thanapprapasr et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Antitumor Effects and Anticancer Applications of Bisphosphonates
Gareth Morgan et al.
SEMINARS IN ONCOLOGY (2010)
Endometrial Cancer Diagnosed by the Presence of Bone Metastasis and Treated with Zoledronic Acid: A Case Report and Review of the Literature
Aiko Shigemitsu et al.
CASE REPORTS IN ONCOLOGY (2010)
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro
Johanna Raikkonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells
B. Karabulut et al.
CELL BIOLOGY INTERNATIONAL (2009)
Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model
Agatha Labrinidis et al.
CLINICAL CANCER RESEARCH (2009)
Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects
M. Marra et al.
CURRENT CANCER DRUG TARGETS (2009)
Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
Penelope D. Ottewell et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients
B. Kotowicz et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats
J. M. Wypij et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients
G Ferretti et al.
ONCOLOGY (2005)
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines
S Kimura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2004)
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
P Tassone et al.
BRITISH JOURNAL OF CANCER (2003)
A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer
R Srivani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
TL Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Distant metastases from cervical esophagus cancer
F Bresadola et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2001)